September 2024 News & Notes
Tive Wins FreightWaves "FreightTech 100" & SupplyChainBrain “Great Supply Chain Partner” Awards
We are proud to announce that we have been included on the FreightWaves 2024 “FreightTech 100” list, and have also been given a SupplyChainBrain “2024 Great Supply Chain Partners” award—both for the third consecutive year. These prestigious recognitions are a tremendous validation of the success our customers are achieving with Tive, as well as our team’s hard work and dedication as we?continue pushing the boundaries of innovation and excellence in the supply chain and logistics space. Read more here.
Livestream: Confronting Ever-Changing Dynamics in Freight Security (w/Supply Chain Now)?
Join Supply Chain Now host Scott Luton as he welcomes Tive’s Richie Daigle and David Shillingford (Co-Founder of Everstream Analytics) to explore the complexities of freight security and supply chain risk management. Second in a three-part series, this livestream—”Confronting Ever-Changing Dynamics in Freight Security”—explains how you can build a resilient tech stack and foster a culture of awareness and adaptability to stay ahead of evolving threats. Register to watch Episode 2 live on October 16, and view Episode 1 on demand now.
Tive CEO Keynotes LogiPharma Boston
Krenar Komoni recently participated in the opening keynote panel at LogiPharma, speaking to a packed room of several hundred people. Joined by executives from Pfizer and Takeda, and moderated by ZS, the group explored the future of end-to-end shipment visibility. Krenar also showed off Tive’s new Solo Lite tracker, and the panel discussed the benefits of switching from passive monitoring to real-time shipment tracking. Krenar also went out on a limb and made a prediction: the days of passive tracking are numbered, and the cost of real-time tracking will decrease—and will be on par with the cost of passive tracking within 3-5 years.
Customer Story: Life Sciences—Keeping Cell & Gene Therapy Shipments Safe for Patients
Powered by groundbreaking cell and gene therapy technology, this innovative Boston life sciences company is committed to delivering a new class of differentiated, one-time curative genetic therapies to address a wide spectrum of diseases. This firm recognized that if they were going to spend precious time developing critical, customized therapies for patients, they needed to ensure that those medicines were protected—across the entire cold chain—so they contacted Tive. Read the story.
领英推荐
Molecules & Megadeals: Our Pharma Industry Special
Want to learn more about pharma, life sciences, and the high-stakes world of medicine supply chains? We deep dive into the power of AI-powered drug supply chains and what KPMG’s latest insights reveal about how life sciences CEOs see the industry. Then, we unpack the BIOSECURE Act drama—which is reshaping U.S./China biotech collaborations, and chase down the red-hot GLP-1 drugs that have supply chains working overtime. Ready for some industry intrigue?
Tive Weighs in on Looming East Coast & Gulf Coast Port Strike
Tive was quoted in a recent article in Supply Chain Management Review—“Assessing the Potential of a Port Strike.” How will the impact of port strikes in the East and Gulf coast areas impact the supply chain? Richie Daigle, supply chain evangelist at Tive, tells Supply Chain Management Review that the complexity involved—from the people and processes to the technology and environmental factors—opens up the supply chain to a multitude of possible disruptions. Read more.
Come Say Hi to Tive!
We would love to meet you! Come visit Team Tive at these upcoming industry events: